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Abstract. For medical device organisations to market their devices in specific 
geographic regions they must adhere to the regulations of that region. These 
regulations often recommend that organisations adhere to specific standards and 
guidance documents which specify “what” must be achieved without specifying 
“how” this may be done. Due to changes to the medical device directive, which 
governs the development of medical devices within the EU, in March 2010, 
software can now in its own right be considered a medical device. This change 
has meant that a number of software organisations developing software for the 
medical device domain must now adhere to the same regulations as other medi-
cal device manufacturers. In this work we present a concept for a Software Pro-
cess Improvement (SPI) roadmap to guide such organisations through the task 
of implementing medical device standards and guidance documents. In addition 
we present and evaluate a methodology that can be used to create a SPI 
roadmap from a set of requirements such as the aforementioned standards and 
guidance documents.   
1 Introduction 
Software can be easily used to configure a medical device without the need for expen-
sive and time consuming hardware changes [1]. In 2006, Faris et al. [2] estimated that 
approximately half of all medical devices on the US market contained software. 
Complexity of software has been increased dramatically, posing higher risks of soft-
ware malfunction and miss-application. Between 2005 and 2009, 87 models of infu-
sion pumps were recalled due to safety problems [3]. In response to this, a whitepaper 
on the use of infusion pumps produced by the FDA, reports that “many of the prob-
lems that have been reported are related to software defects”. 
Although this is only one example, recent trends show that an increasing number of 
medical devices are being recalled due to software failures. Due to the increasingly 
important role of software in these devices, software is now included in the EU’s 
definition of a medical device [4] subjecting it to the same processes and standards as 
other medical devices.  
To ensure compliance, organisations are facing the challenge of implementing a 
number of medical device standards and guidance documents. These standards and 
guidance documents clearly define what must be achieved without providing specific 
methods for achieving them [5]. 
In this work we aim to alleviate this problem through the use of a series of software 
process improvement roadmaps. These roadmaps will not only outline what an organ-
isation must do and when it should be introduced (in line with the software develop-
ment lifecycle), but will also provide specific guidance on the best way to achieve 
these requirements for individual organisations. 
Previous work by the authors [6] has outlined the structure of these roadmaps and 
proposed a methodology for their development. In this paper we aim to re-evaluate 
this methodology in light of its application to two medical device standards, IEC 
62366[7] and ISO 14971[8], and to share our experiences in the application of the 
methodology to allow future researchers learn from these experiences.  
The remainder of this paper is structured as follows: Section 2 outlines the back-
ground to this work and discusses the importance of software to the medical device 
domain. Section 3 examines the role of software processes and software process im-
provement within the medical device domain. In section 4 we describe the structure of 
the roadmaps and a methodology for their development. Section 5 then discusses how 
the roadmap development methodology was applied to two international standards 
and discusses the impact this will have on the methodology in the future. Section 6 
then concludes the paper with an outline of how this work will progress. 
2 Related Work 
2.1 Medical Device Regulations, Standards and Guidance Documents 
In order to sell a medical device within the European Union (EU), the medical device 
organisation must demonstrate that they are compliant with the regulations set forth 
by the EU. Similarly, to sell medical devices within the US the organisation must 
demonstrate compliance with the FDA regulations [9]. In order to help organisations 
achieve compliance with these regulations, the EU and FDA have published standards 
and guidance documents that address specific aspects of the regulations and also rec-
ommend compliance with harmonised and consensus international standards, such as 
IEC 62304 [12] and ISO 13485 [10]. ISO 13485 Quality management system (QMS) 
ensures that the processes used during the development and production of a medical 
device are defined and monitored to ensure high quality products are developed. This 
standard is referred to by the European regulations and has recently been accepted by 
the FDA as adequate fulfilment of the requirements of a QMS. 
As part of the QMS, organisations must perform risk management activities.. ISO 
14971:2007 [8] describes the requirements of a risk management process for medical 
device development. This standard identifies 6 key stages of a risk management; risk 
analysis, risk evaluation, risk control, evaluation of overall residual risk acceptability, 
risk management report, and production and post-production information. 
During the development of a medical device, it is important to consider how the 
user will interact with it. Usability (the extent to which a product can be used by spec-
ified users to achieve specified goals with effectiveness, efficiency and satisfaction in 
a specified context of use [11]) can be a source of great risk. The IEC 62366 [7] 
standard defines a usability engineering process that can help medical device devel-
opers produce usable products thereby reducing the risk of use errors.  
IEC 62304:2006 – Medical device software – Software life cycle processes [12] 
provides specific guidance on how to perform software development activities for 
software that is to be incorporated in a medical device. It is therefore used to develop 
medical device software for both the European and US markets. 
3 Software Process and Improvement 
Software process improvement analyses existing software development processes 
with a view to continually improve these processes through a series of additional re-
fined practices. This approach has provided many benefits to organisations including 
higher quality software, improved productivity and reduced time to market [13-19]. 
The Software Engineering Institute has set out a roadmap for the undertaking of a 
software process improvement initiative [20]. This report identifies three main phases; 
First phase is to initiate the process improvement initiative which involves learning 
about SPI, committing initial resources and building a process infrastructure. The next 
phase is to baseline the current state of the organisations software processes. This is 
achieved through the undertaking of a software process improvement assessment, 
such as ISO/IEC 15504-5:2012 [21] (SPICE) or Capability Maturity Model® Integra-
tion (CMMI®) [22]. During an assessment the organisations current processes are 
assessed and measured, and any weakness or shortcomings are identified. The final 
phase of the software process improvement initiative is to implement or deploy the 
software process improvements.  
3.1 Software Process Improvement within the Medical Device Domain 
There has been very limited adoption of software process improvement within the 
medical device domain [4]. In addition existing generic SPI models, such as the 
CMMI® and  ISO/IEC 15504-5:2012 (SPICE), do not provide sufficient coverage to 
achieve medical device regulatory compliance [25] [2] [13] [1].  To address this issue 
a medical device specific SPI framework, titled Medi SPICE, is being developed [26].  
The objective of undertaking a Medi SPICE assessment is to determine the state of 
a medical device organisation’s software processes and practices, in relation to regu-
latory requirements and best practices with the goal of  identifying  areas for under-
taking process improvement [25] [2] [2] [1] [1] [13] [1].  It can also be used as part of 
the supplier selection process [27].  
Medi SPICE is based on ISO/IEC 15504-5:2012 [21], IEC 62304:2006 [12] and 
ISO/IEC 12207:2008 [28]. It is being developed in line with the requirements of 
ISO/IEC 15504-2:2003 [29] and contains a Process Reference Model (PRM) and 
Process Assessment Model (PAM). It also incorporates the requirements of the rele-
vant medical device regulations, standards, technical reports and guidance documents. 
The Medi SPICE PRM consists of 44 processes and 15 sub-processes with clearly 
defined purpose and outcomes that must be accomplished to achieve that purpose. 
The Medi SPICE PAM which is related to the PRM, forms the basis for collecting 
evidence that may be used to provide a rating of process capability.  
4 Software Process Improvement Roadmaps 
In this work we propose the use of a software process improvement framework for the 
implementation of medical device standards. Unlike traditional SPI models, the goal 
of the roadmap implementation framework is not to improve existing processes but to 
implement the processes necessary to meet the requirements of a specific standard. 
Initially this work will focus on the development of SPI roadmaps for key medical 
device standards; IEC 62366, ISO 14971, ISO 13485 and IEC 62304. 
For the purposes of this work we define a roadmap as: A series of milestones, com-
prised of goals, that will guide an organisation, through the use of specific activities, 
towards compliance with regulatory standards. 
The roadmap is divided into two levels. The first level defines the goals, grouped 
into milestones that the organisation should achieve throughout the SPI initiative. And 
contains no detail relating to how the goals should be achieved. This is done for two 
reasons. Firstly, by presenting the roadmap as a series of goals traceability to the rele-
vant standard can be easily achieved. Secondly, the high-level roadmap can form a 
basis for communication across the industry as the same high-level roadmap can be 
applied to all organisations. The second level roadmap contains specific guidance for 
organisations on how to achieve the goals outlined in the high level roadmap and is 
comprised of multiple activities that can achieve each goal so that the most suitable 
activity can be presented to an organisation wanting to implement the roadmap. 
4.1 Roadmap Development Methodology 
The following approach is similar to the transformation method presented in [31] for 
the construction of ISO/IEC 15504-2 compliant process assessment and process refer-
ence models. The goal of the transformation methodology presented in [31] was to 
develop a process reference model and a process assessment model. As the goal of 
this methodology is to develop a roadmap for implementing medical device standards 
it was necessary to alter the methodology to account for the order of implementation 
and the distinction between the goals and activities (or practices in ISO 15504) in the 
roadmap. 
The methodology used for the development of the roadmaps is as follows: 
1. Identify requirements of the standard: (The requirements will henceforth 
be known as ‘goals’ to differentiate the roadmap from the standard). This 
will be achieved through manual analysis of the standard. 
2. Logically group all goals. Goals are grouped based on the stage of the soft-
ware development lifecycle at which they occur. However as some goals are 
performed throughout the lifecycle, these goals should be grouped together 
and placed at or before the first stage at which they are performed. 
3. Separate grouped goals in line with ISO/IEC 15504 capability levels. 
These groups are separated based on the capability level at which the re-
quirements should be performed. These groups form the milestones of the 
roadmap. 
4. Order the milestones based on the capability level and logical groups. 
All milestones containing level 1 goals should be implemented first in the 
order in which they will occur in the development process, followed by all 
milestones containing level 2 goals, and subsequently by all milestones con-
taining level 3 goals until all of the milestones are in order. 
5. Validate generated roadmap. The generated roadmap should be validated 
with industry experts. Members of the standards committee could also assist 
with the validation. Interviews or workshops are methods that could be used. 
A Delphi study could also be used. The validation should aim to ensure that: 
• The goals are correctly grouped 
• The milestones are in the correct order for implementation  
6. Identify activities that can meet the identified goals.. This can be done 
through a systematic literature review and/or case studies with organisations 
already implementing the standard. 
7. Validate activities in host organisation. This will involve the generation of 
a roadmap for the host organisation and then undertaking a software process 
improvement initiative to implement the roadmap. 
5 Evaluation 
This section presents two case studies that have used the roadmap development meth-
odology to develop and validate a high-level roadmap for two medical device stand-
ards(IEC 62366 and ISO 14971). A full description of the developed roadmaps is 
beyond the scope of this experience report. 
5.1 Validation Methodology 
To validate each of the roadmaps an expert evaluation was used. There were two 
aims established for each validation: 
1. To determine if the goals are appropriately grouped into milestones 
2. To determine if the ordering of the milestones is appropriate for implementa-
tion in a medical device organisation. 
Experienced personnel within each of the two domains, risk management and usa-
bility of medical devices, were asked to complete the on-line questionnaire illustrated 
in Figure 1. The questionnaire showed participants each milestone in turn and asked 
them to state whether they thought each goal belonged in the milestone it was includ-
ed in. In addition the participants were asked to rate on a 5 point likert scale (where 1 
= strongly disagree and 5 = strongly agree) whether they agreed with the following 
statement; The order of this milestone within the roadmap is correct. The participants 
were also provided with the opportunity to add any additional comments they felt 
were relevant. 
 Fig. 1. Screenshot from online questionnaire 
In addition to this, the online questionnaire also provides the user with the oppor-
tunity to state at what capability level, in line with 15504-2, each goal should be ac-
complished at. As the participants who took part in the study were experts in medical 
device standards and not software process improvement these results were not includ-
ed in the study. However we did manage to recruit 1 software process improvement 
expert whose feedback is included. 
5.2 Case Study 1- IEC 62366 
The first case study conducted applied the roadmap development methodology to the 
IEC 62366 standard. This standard outlines the requirements for a usability engineer-
ing process and describes what needs to be done to minimise use related risks. The 
standard requires the development of a number of documents, including a usability 
engineering file which should at least reference all of the documentation relating to 
the usability engineering process. 
Step 1 of the methodology identified 44 goals, that were separated into 10 milestones 
(step 3) that are implemented throughout the software development lifecycle. Table 1 
shows the number of goals that were included in each of the milestones for the IEC 
62366 roadmap. It can be seen that the number of goals range from 2 to 7 per mile-
stone. 
  
 Table 1. Initial IEC 62366 Roadmap 
Milestone # of goals Milestone # of goals 
Task 5 Training 4 
Usability Specification 5 Verification 4 
Risk Management 7 Validation 4 
Implementation 2 Validation Management 3 
Documentation 6 Process  4 
 
Once the roadmap was produced it was validated by 5 participants with experience of 
usability engineering for medical devices. In total 18 individuals were contacted in 
relation to the validation however, only 5 agreed to participate in the study. Overall 
the participants felt that the initial roadmap was well structured, however they did feel 
that the last two milestones should be implemented earlier. It was felt that the Process 
milestone should be the first milestone as it defines and maintains the overall process 
of usability engineering. 
Although a full overview of the results is beyond the scope of this paper, it is im-
portant to mention that the results obtained in relation to the capability level of each 
goal provided little agreement among the participants. This result may be explained 
by the participants’ area of expertise being in the area of usability engineering and not 
in ISO 15504 capability levels. 
As a result of the validation, the roadmap was revised to include only 39 goals (some 
of the original goals were merged where the documentation of an activity and the 
activity itself were separate goals) divided into 9 milestones. Two milestones, valida-
tion and validation management, were merged to form a single goal as these were 
originally separated based on their capability level. Table 2 shows the number of 
goals by milestone for the revised roadmap. 
Table 2. # of goals in the revised IEC 62366 roadmap  by milestone 
Milestone # of goals Milestone # of goals 
Process 3 Documentation 6 
Task 3 Training 4 
Usability specification 4 Verification 4 
Risk Management 6 Validation 7 
Implementation 2   
5.3 Case Study 2 – Roadmap for ISO14971 
The second case study applied the roadmap development methodology to the ISO 
14971 standard. ISO 14971 describes the risk management process that should be 
applied during the development of medical devices. The standard itself is not limited 
to software but can apply to any type of medical device. The standard outlines a 6 
phase risk management process ranging from risk analysis, which is the identification 
of possible risks posed by the medical device to Production and post-production man-
agement of any residual risks.  
The roadmap generated by the roadmap development methodology contained 51 
goals divided among 14 milestones. Table 3 shows that there are between 1 and 7 
goals per milestone in the roadmap. As risk management is an on-going activity with 
each stage being repeated throughout the software development lifecycle, the 
roadmap should be used to introduce the goals early in the product lifecycle so that 
the necessary activities are in place when needed. 
Table 3. # of goals per milestone 
Milestone # of 
Goals 
Milestone # of 
Goals 
Initial Planning 6 Pre-Production 1 
Risk Analysis 4 Post-Production 2 
Risk Evaluation 3 Management Planning 4 
Risk Control 3 Staff Planning 4 
Verification of Risk Control 5 Final Review 2 
Residual Risk 7 Risk Management System Review 3 
Pre-Release 6 Traceability 1 
 
As was found in case study 1, the validation of the roadmap found that a number of 
the milestones, which contained goals believed to be at capability level 2 (Managed 
process- the process meets the requirements for capability level 1 where the process is 
performed, and is now implemented in a managed fashion), were introduced too late 
in the roadmap and as such should be introduced earlier. In addition it was also found 
that in a number of cases the separation of an activity from its documentation was 
unnecessary and these goals should be grouped into a single goal. 
The validation resulted in a number of changes to the roadmap. The resulting 
roadmap contains 44 goals divided among 14 milestones. Three of the final 4 mile-
stones were moved so that they would be implemented at the beginning of the imple-
mentation process. The final number of goals and order of the milestones can be seen 
in table 4 (read from top to bottom, then left to right). 
Table 4. # of goals per milestone in the ISO 14971 Roadmap 
Milestone # of 
Goals 
Milestone # of 
Goals 
Initial Planning 6 Verification of risk Control 3 
Management Planning 3 Residual Risk 7 
Staff Planning  3 Pre-Release 6 
Traceability 1 Pre-Production 1 
Risk Analysis 4 Post-Production 1 
Risk Evaluation 3 Risk Management System Review 3 
Risk Control  2 Final Review 1 
6 Discussion 
The case studies described above have provided a lot of insight into the methodology 
and have highlighted a number of issues that can arise when applying it to medical 
device standards.  
The first stage is to determine the requirements of the standards. The standards con-
tain a lot of supporting information which can be difficult to discern from the re-
quirements. The authors judgement was used in determining this and the validation 
found that these judgements were correct. Additionally, it was found that the stand-
ards use consistent terminology to describe what needs to done in order to be in com-
pliance with the standard.. This consistency could also allow for the use of Natural 
Language Processing (NLP) techniques to identify the requirements from the stand-
ard.  
During the application of step 2 (logically group all goals) it was identified that not all 
processes can adhere to the software development lifecycle. In the cases outlined 
above it was found that there were logical groupings that could be easily identified 
however, some requirements would not easily fit into these groupings. For example in 
case study 2 it can be seen that 2 of the milestones contained only a single goal. Alt-
hough the methodology itself can be quite flexible it was found in both case studies 
that dividing the goals based on their capability level provided little benefit as most of 
the goals should be implemented by a level 1 organisation. During case study 1, an 
ISO 15504-2 expert was asked to review the goals to determine if they were assigned 
an appropriate capability level. This expert remarked that as they are a requirement of 
the standard they should all be assigned a capability level of 1. For this reason it has 
been determined that this step (step 3) should be removed from the methodology. 
In the cases outlined above it was found that the logical groupings provided a clear 
path to implementation. The use of the ISO 15504 capability levels in this step how-
ever, did cause problems. Some of the goals that were determined to be implemented 
at level 2 are necessary at the start of the implementation, for example the develop-
ment of a standard operating procedure. Including these levels in the ordering of the 
milestones lead to the development of inaccurate roadmaps that was quickly identified 
by the experts. The case studies also revealed that it is important to select the correct 
method for validation. In both cases an online form was used to collect the opinions 
of the validators on the roadmap. Although this approach provided sufficient valida-
tion for the two standards selected, this may not scale well due to the large number of 
inputs that would need to be completed. In case study 2 one participant opted to email 
their comments directly to the author instead of completing the online form. To ad-
dress this issue future validation studies may instead opt to take on a different format. 
One possibility is the use of a workshop whereby the participants are co-located and 
presented with the roadmap and provided an opportunity to discuss the roadmap in 
much more detail. 
During the case studies it was found that the separation of the documentation of an 
activity from the activity itself, as was done in a number of cases, should not be done. 
One of the validators remarked that “If it’s not documented, it’s not done”, and sug-
gested that the documentation of an activity should not be a separate goal but incorpo-
rated into the activity that is being performed.  
7 Revised Roadmap Development Methodology 
As a result of the validation the methodology now consists of: 
1. Identify requirements of the standard: It is important to ensure that re-
quirements of the standard are identified and distinguished form supporting 
advice. These requirements should then be phrased as goals of the roadmap. 
2. Logically group all goals. Each group should not contain too many goals. If 
this is the case they may be separated into multiple sub-groups. The resulting 
groups will form the milestones for implementation. 
3. Order the milestones based on the logical groups. The milestones should 
ordered in a way that is compatible with implementation in a software devel-
opment process to ensure that organisations suffer limited disruption due to 
the implementation. 
4. Validate generated roadmap. The validation should be performed with in-
dustry experts and evaluate the roadmap to answer the following questions: 
 Are the goals appropriately grouped into milestones? 
 Is the ordering of the milestones appropriate for implementation in a 
medical device organisation? 
5. Identify activities that can meet the identified goals.. This may be done 
through a systematic literature review and/or case studies with organisations 
already implementing the standard. 
1.6. Validate activities in host organisation.. Generate a roadmap for the host 
organisation through collaboration between the organisation and industry 
experts and then undertaking a software process improvement initiative to 
implement the roadmap. 
8 Limitations 
The validation described above did not include development of the activities reposito-
ry or industry validation of a complete roadmap. For this reason the validation pre-
sented above is limited to the first 5 steps of the methodology which can be used to 
develop a high-level roadmap. This in itself in a vital aspect to the development of 
software process improvement roadmaps. 
The development methodology has been applied to two standards within the medical 
device domain. Before it can be established that the methodology can be applied as is 
to other domains, such as the automotive or aerospace domains, it must be validated 
within these domains.  
9 Conclusions and future work 
The implementation of any standard required in the development of medical devices 
can be a complex and time consuming issue. SPI roadmaps provide specific activities, 
in-line with the medical device standards, for an organisation to implement the chosen 
standard in a way that complements existing software development lifecycle process-
es. 
This paper outlines how such roadmaps can be developed through the use of the 
roadmap development methodology and report on the application of this methodology 
to two medical device standards, IEC 62366 and ISO 4971. In light of these case stud-
ies it was deemed that the methodology can be used to develop high level software 
process improvement roadmaps that would be well received by the medical device 
community. 
In the future this work will examine the use of Natural Language Processing (NLP) 
techniques to assist in the development of such roadmaps, in line with the roadmap 
development methodology. NLP techniques could be used to automatically identify 
the requirements of a medical device standard, the first step in the presented method-
ology. This could greatly simplify the process of roadmap development as the identi-
fication of such requirements can be a time consuming task. 
Using the roadmaps presented here, it is intended to recruit a number of medi-
cal device organisations to implement the roadmaps to evaluate how well the 
proposed roadmaps work in an industry setting. After an initial evaluation of 
the organisations existing processes, a customised roadmap will be developed 
for the organisation and they will be guided through its implementation, until 
they have met all of the requirements of the medical device standard 
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